CSL Behring, a subsidiary of CSL Limited, is a global biotechnology company that was established in 1901. Based in Melbourne, Australia, the company specializes in research, development, and manufacturing of biotherapies used to treat serious and rare conditions. These include immunodeficiency, haemophilia, hereditary angioedema, and respiratory diseases. As of my knowledge cutoff in 2021, they employ over 27,000 people across 30+ countries.  CSL Limited Annual Report 2021/22 13 Operating Review CSL Behring Total revenue was US$8,598 million.